Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

4P Ken Gillman

 

Summary for 2006 [at-glance overview of P Ken Gillman work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author P Ken Gillman. According to available data, in 2006 P Ken Gillman published at least 4 articles. In this work P Ken Gillman has collaborated exclusively with Lawrence, Kenneth R resulting in 1 joint articles. There is no information about the funding or the grants awarded to support this work.

P Ken Gillman is a key opinion leader in the specific area of Serotonin Syndrome. This author's rank is 1 when compared to all other authors using the same keyword. Analysis of the article abstracts and the titles suggests that P Ken Gillman professional interests are focused around "precipitate serotonin toxicity", "mirtazapine humans implications" and "review serotonin toxicity". These might also be referred to as "serotonin toxicity", "serotonergic effects" or "use linezolid". Statistical analysis shows that P Ken Gillman's writing is likely to contains terms "serotonin", "toxicity", "effects", "serotonergic", "mirtazapine" and "drug".

Unfortunately, there is not enough information to establish P Ken Gillman affiliation. Luckily, several email addresses are on file.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for P Ken Gillman]

    loading...

    Do you know P Ken Gillman who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to P Ken Gillman]

Year 2006 Charts [P Ken Gillman frequent coauthors and the most common unique vocabulary terms for the selected year]

  • P Ken Gillman - Coauthors & Social Network in 2006P Ken Gillman - Unique Vocabulary, Keywords and Interests in 2006

Historical Performance Charts [graphical overview of P Ken Gillman publication and funding history for the range of years]

  • P Ken Gillman - Publications and Funding History in 2006

Emails (2) [email addresses extracted from P Ken Gillman affiliations]

hidden to prevent spam, click here to reveal

P Ken Gillman Coauthors (1) [all coauthors with the number of joint publications]

1

2Lawrence, Kenneth R

 

Other [context-specific ads]

Affiliations (3) [condensed summary of the P Ken Gillman affiliations, the leading number and the color conveys importance]

  • 1Tufts-New England Medical Center, Department of Pharmacy, Boston, Massachusetts 02111, USA.
    1Department of Clinical Neuropharmacology, Pioneer Valley Private Hospital, North Mackay, Queensland, Australia.
    1Pioneer Valley Private Hospital, Australia.

Key Opinion Leader In [P Ken Gillman is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 1Serotonin Syndrome

Keywords (19) [keywords assigned to P Ken Gillman articles by PubMed, the leading number and the color conveys importance]

  • 4Humans | 3Serotonin Syndrome | 2Drug Interactions | 2Animals | 2Monoamine Oxidase Inhibitors | 2Antidepressive Agents | 2Serotonin | 1Overdose | 1Rats | 1Adrenergic alpha-Antagonists | 1Oxazolidinones | 1Acetamides | 1Receptor, Serotonin, 5-HT1A | 1Anti-Bacterial Agents | 1Risk Assessment | 1Mianserin | 1Medical Records | 1Product Surveillance, Postmarketing | 1Databases as Topic

P Ken Gillman Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Ken Gillman might be a good expert witness on these terms]

  • 24serotonin | 19toxicity | 11effects | 9serotonergic | 8mirtazapine | 8drug | 8data | 7st | 7review | 6drugs | 6evidence | 5humans | 5action | 4linezolid | 4implications | 4patients | 3antidepressant | 3inhibitors | 3precipitate | 3dual | 3use | 3mechanisms | 3systematic | 2monoamine | 2concept | 2status | 2mianserin | 2combination | 2animals | 2oxidase | 2prescribers | 2exhibit
  • 16serotonin toxicity | 6serotonergic effects | 3use linezolid | 3dual action | 3precipitate serotonin | 3systematic review | 2review serotonergic | 2toxicity data | 2implications mechanisms | 2oxidase inhibitors | 2monoamine oxidase | 2mirtazapine humans | 2humans implications | 2action status | 2antidepressant drug | 2mechanisms antidepressant | 2drug action | 2toxicity st | 2effects mirtazapine | 2implications dual | 2effects humans | 2data implications | 2review serotonin | 2linezolid review | 2associated use | 2unable precipitate | 2nervous system | 2toxicity overdose | 2potency drug | 2review postmarketing | 2postmarketing data | 2central nervous
  • 3precipitate serotonin toxicity | 2mirtazapine humans implications | 2review serotonin toxicity | 2monoamine oxidase inhibitors | 2serotonin toxicity st | 2effects mirtazapine humans | 2toxicity data implications | 2dual action status | 2implications mechanisms antidepressant | 2mechanisms antidepressant drug | 2systematic review serotonergic | 2review serotonergic effects | 2humans implications dual | 2serotonergic effects mirtazapine | 2implications dual action | 2serotonin toxicity data | 2data implications mechanisms | 2antidepressant drug action | 2toxicity associated use | 2linezolid review postmarketing | 2serotonin toxicity overdose | 2review postmarketing data | 2unable precipitate serotonin | 2associated use linezolid | 2use linezolid review | 2central nervous system | 2serotonin toxicity associated | 1thirteen patients required | 1form poisoning idiosyncratic | 1drugs received concurrently | 1diagnosis mirtazapine demonstrable | 1analogue mianserin serotonergic

Reader's Comments (2) [comments posted by readers of P Ken Gillman profile]

Reader Correction: [Gillman, P Ken] in 2009 [posted by Ken Gillman on Sun, 21 Feb 2010 13:52:15 GMT]

[1] Gillman PK. Mechanisms, management and measurement in atropine induced hyperthermia. Anaesth Intensive Care. 2009;37:322-3.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19400503
[2] Gillman PK. Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity? Am J Emerg Med. 2009;27:509-10.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19555629
[3] Gillman PK. Fentanyl and serotonin toxicity. Br J Anaesth. 2009:http://bja.oxfordjournals.org/cgi/eletters/95/4/434#4135.


[4] Gillman PK. Lessons continue: serotonin toxicity. Consult Pharm. 2009;24:398-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19694109
[5] Gillman PK. Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review. Headache. 2009;50:264-72.
10.1111/j.1526-4610.2009.01575.x. PMID: 19925619.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19925619
[6] Gillman PK. In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine". J Med Toxicol. 2009;5:259.
10.1007/BF03178278.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20012252
[7] Gillman PK. Myths about MAOIs uncritically perpetuated. Aust N Z J Psychiatry. 2009;43:[in press].


[8] Gillman PK. In Reference to Parathyroid Surgery and Methylene Blue: a Review with Guidelines for Safe Intraoperative Use. Laryngoscope. 2010;120:436-7.
PMID: 19950381.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19950381
[9] Gillman PK. Combining antidepressants: Understanding Drug Interactions is the Sine Qua Non. Adv Psychiatr Treat. 2010;16:76-8.
10.1192/apt.16.1.76.

[10] Gillman PK. More on Mrs Murphy’s beans: or ‘do us a fava’. J Clinic Psychopharmacol. 2010;30:[In Press].


[11] Schwiebert C, Irving C, Gillman PK. Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity. Anaesthesia. 2009;64:924-.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19604213
[12] Stanford SC, Stanford BJ, Gillman PK. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol (Oxf). 2009 May 7:10.1177/0269881109105450.
10.1177/0269881109105450. 19423610.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19423610

Reader Comment: [Gillman, P Ken] in 2009 [posted by Ken Gillman on Thu, 11 Feb 2010 09:55:19 GMT]

My pubs 2009/10
[1] Gillman PK. Meperidine (pethidine) and toxicity. Br J Anaesth. 2010
http://bja.oxfordjournals.org:80/cgi/eletters/103/3/369#5444
[2] Gillman PK. More on Mrs Murphy’s beans: or ‘do us a fava’. J Clinic Psychopharmacol. 2010;30:[In Press].


[3] Gillman PK. Combining antidepressants: Understanding Drug Interactions is the Sine Qua Non. Adv Psychiatr Treat. 2010;16:76-8.
10.1192/apt.16.1.76.

[4] Gillman PK. In Reference to Parathyroid Surgery and Methylene Blue: a Review with Guidelines for Safe Intraoperative Use. Laryngoscope. 2010;120:436-7.
PMID: 19950381.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19950381
[5] Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol (Oxf). 201010.1177/0269881109359098.
http://jop.sagepub.com/cgi/doi/10.1177/0269881109359098
[6] Stanford SC, Stanford BJ, Gillman PK. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol (Oxf). 2009 May 7:10.1177/0269881109105450.
10.1177/0269881109105450. 19423610.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19423610
[7] Schwiebert C, Irving C, Gillman PK. Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity. Anaesthesia. 2009;64:924-.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19604213
[8] Gillman PK. Monoamine Oxidase Inhibitors, Dietary Tyramine and Drug Interactions. 2009:[accessed Dec 2009].

http://psychotropical.com/pdfs/maois_diet_full.pdf
[9] Gillman PK. Myths about MAOIs uncritically perpetuated. Aust N Z J Psychiatry. 2009;43:[in press].


[10] Gillman PK. The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine. J Med Toxicol. 2009:[in press].


[11] Gillman PK. Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review. Headache. 2010;50:264-72.
10.1111/j.1526-4610.2009.01575.x. PMID: 19925619.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19925619
[12] Gillman PK. Lessons continue: serotonin toxicity. Consult Pharm. 2009;24:398-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19694109
[13] Gillman PK. Fentanyl and serotonin toxicity. Br J Anaesth. 2009:http://bja.oxfordjournals.org/cgi/eletters/95/4/434#4135.


[14] Gillman PK. Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity? Am J Emerg Med. 2009;27:509-10.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19555629
[15] Gillman PK. Mechanisms, management and measurement in atropine induced hyperthermia. Anaesth Intensive Care. 2009;37:322-3.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19400503

Funding (0) [selected NIH grants to P Ken Gillman and the award amounts for recent years]

  • award information is not available

P Ken Gillman Articles (4) [selected PubMed articles for the year 2006 with the links to a full text at PubMed]

  • Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. (2006) >>

    Tufts-New England Medical Center, Department of Pharmacy, Boston, Massachusetts 02111, USA.

    2Lawrence, Kenneth R, 2Adra, May, 4Gillman, P Ken.

  • A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. (2006) >>

    Department of Clinical Neuropharmacology, Pioneer Valley Private Hospital, North Mackay, Queensland, Australia.

    4Gillman, P Ken.

  • Extracting value from case reports: lessons from serotonin toxicity. (2006) >>

    4Gillman, P Ken.

  • A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. (2006) >>

    Pioneer Valley Private Hospital, Australia.

    4Gillman, P Ken.

Science Trivia (2) [Interactive math & science trivia questions]